Les adipocytokines: lien entre obésité, diabète de type 2 et athérosclérose [Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis]

Détails

ID Serval
serval:BIB_E66CD3A2C2FE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Les adipocytokines: lien entre obésité, diabète de type 2 et athérosclérose [Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis]
Périodique
Revue médicale de Liège
Auteur⸱e⸱s
Paquot N., Tappy L.
ISSN
0370-629X
Statut éditorial
Publié
Date de publication
06/2005
Volume
60
Numéro
5-6
Pages
369-373
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review
Résumé
Adipose tissue, in addition to the storage of lipids function for lipids, plays active roles in normal metabolic homeostasis and in the development of several diseases, such as type 2 diabetes, dyslipaemia and atherosclerosis. These roles are mediated by adipocytokines, factors secreted by adipose tissue. These include tumor necrosis factors (TNF)-alpha, leptin, resistin, adiponectin or visfatin. Adipocytokines act in an autocrine, paracrine and endocrine manner. Adiponectin is a peculiar adipocytokine because in contrast to the markedly increased levels of leptin, resistin or TNF-alpha in obesity, its level is negatively correlated with body mass index, and is decreased in presence of insulin resistance and in type 2 diabetes. Adiponectin may play a crucial role in the development of diabetes mellitus and high adiponectin levels should protect against impairment of glucose metabolism. Moreover, adipocytokines are involved in the pathogenesis of vascular diseases and may represent a link between obesity, diabetes, inflammation and atherosclerosis. Weight loss, exercise and some antidiabetic drugs also influence plasma adipocytokines levels. For instance, thiazolidinediones treatment in patients with type 2 diabetes resulted in an increased in plasma adiponectin levels and a decrease in circulating TNF-alpha concentrations.
Mots-clé
Adiponectin, Adipose Tissue/chemistry, Adipose Tissue/physiology, Arteriosclerosis/physiopathology, Cytokines/physiology, Diabetes Mellitus, Type 2/physiopathology, Exercise, Glucose/metabolism, Humans, Insulin Resistance, Intercellular Signaling Peptides and Proteins/physiology, Obesity/complications, Obesity/physiopathology, Weight Loss
Pubmed
Création de la notice
24/01/2008 13:36
Dernière modification de la notice
20/08/2019 16:09
Données d'usage